BIOLASE, Inc., the global leader in dental lasers, announced that it has partnered with Project HOME, an organization that provides dental services to patients from their first birthday to adulthood. Project HOME’s Healthcare Services is a Federally Qualified Health Center (FQHC) and supports health care services, regardless of a person’s ability to pay for the… Continue reading Biolase Announces Support for Project Home
Category: Medical Devices
Read Magazine provides latest news and granular market insights from the Medical Devices, Covid19, Pandemic, Pharma, and allied domains.
How Can Digitalization of Medical Devices Boost Productivity in Medtech
The global medical devices industry is undergoing a major transformation in business models, technology adoption, and care delivery approaches, according to Frost & Sullivan’s recent analysis, Global Medical Devices Outlook. The digitalization of medical devices encourages medtech players to deliver value for providers and patients with devices and digital data. This is leading to the… Continue reading How Can Digitalization of Medical Devices Boost Productivity in Medtech
CAPS Medical Enrolls Patients from Sheba Medical Center in First Ever Study for Treatment of Bladder Cancer Using Selective Endoscopic Cancer Treatment Technology
CAPS Medical, developer of a highly selective and minimally invasive non-thermal plasma (NTAP™) device for cancer treatment, announced today the enrollment of the first patients in a multi-center study to assess the safety and technical performance of their NTAP™ system in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC). The cancer patients in the… Continue reading CAPS Medical Enrolls Patients from Sheba Medical Center in First Ever Study for Treatment of Bladder Cancer Using Selective Endoscopic Cancer Treatment Technology
Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications
Imaging diagnostics company Magnetic Insight today announced $17 million in Series B funding led by Celesta Capital, with participation from Alumni Ventures Group, Gaingels, and others, along with existing investors 5AM Ventures and Sand Hill Angels. The funding will support Magnetic Insight’s continued growth and expansion of its innovative Magnetic Particle Imaging (MPI) technology into… Continue reading Magnetic Insight Raises $17M Series B to Expand Magnetic Particle Imaging and Monitoring Technology into Clinical Applications
Berry Oncology Launches HIFI Pan-Cancer Screening, a Multi-Cancer Early Screening Product
Berry Oncology, a global leading company specialized in genomic testing and early cancer screening, announced the launch of its innovative one-time precision product HIFI Pan-Cancer Screening, which is an early multi-cancer screening product developed based on the company’s proprietary HIFI technology platform. With one single testing, the product can accurately detect 6 high-risk and high-incident… Continue reading Berry Oncology Launches HIFI Pan-Cancer Screening, a Multi-Cancer Early Screening Product
Devyser Wins Breakthrough Contract in Canada for Non-invasive Fetal RHD testing
Devyser has been awarded a tender from Héma-Québec, in Québec, Canada, for its non-invasive fetal RHD detection product, used to determine fetal RHD status from maternal plasma in early pregnancy. The tender is initially valid over three years starting in 2023, with a potential extension of two additional years. The total possible order value amounts… Continue reading Devyser Wins Breakthrough Contract in Canada for Non-invasive Fetal RHD testing
First American Patient Treated with VenusP-Valve Under Compassionate Use
VenusP-Valve, an in-house developed novel medical device of Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as “Venus Medtech”), recently completed its first compassionate use at University of Virginia Advanced Cardiac Valve Center in the U.S. Also Read: New Korus Technology Set to Transform Industry Standards in Elutriation and Cell Wash The procedure was performed… Continue reading First American Patient Treated with VenusP-Valve Under Compassionate Use
3Spine, Inc. Announces IDE Approval
3Spine, Inc., a medical device company developing total joint replacement for the lumbar spine, announced FDA Investigational Device Exemption (IDE) approval for their US pivotal clinical trial. The company previously completed contracting and site initiation at 16 US centers for a prospective real-world evidence (RWE) fusion study, which has been enrolling since May 2021. As… Continue reading 3Spine, Inc. Announces IDE Approval
Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT
Alpha Tau Medical Ltd., the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced that the first patient was treated in a feasibility study evaluating the Alpha DaRT as a neoadjuvant therapy in patients with prostate cancer at the Rambam Health Care Center in Haifa, Israel. Also Read: New Korus Technology Set to Transform… Continue reading Alpha Tau Announces Treatment of First Prostate Cancer Patient with Alpha DaRT
MCRA and Clients Achieve Significant Milestone – Over 60 Breakthrough Device Designations
MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory Affairs, Clinical Trial Operations, Reimbursement and Market Access, Healthcare Compliance, Cybersecurity, and Quality Assurance support is excited to announce its role in the successful granting of over 60 breakthrough device designations by the Food and… Continue reading MCRA and Clients Achieve Significant Milestone – Over 60 Breakthrough Device Designations